Mylan Agrees to Give EpiPen Documents to Congress

September 13, 2016

According to CNN Money, on August 29, 2016, The House Oversight Committee sent Mylan a letter requesting more information regarding EpiPen sales. The committee is expecting the documents, which will include Mylan's profits from EpiPen sales, by September 15 or 16. "'While the medicine that actually stops an adverse reaction is remarmkably cheap -- only a few cents per dose -- it is the delivery mechanism that is breaking the bank of many American,' committee leaders wrote in the letter to Mylan."